These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 31964157)

  • 21. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis.
    Li J; Ma Z; Yang Z; Yang M; Li C; Li M; Li X; Chen X; Ma H; Chen W; Ye X; Li X
    J Ethnopharmacol; 2024 Mar; 322():117600. PubMed ID: 38103844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking.
    Yang J; Tang C; Jin R; Liu B; Wang P; Chen Y; Zeng C
    Sci Rep; 2022 Apr; 12(1):5526. PubMed ID: 35365737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Huanglianjiedu Decoction as an effective treatment for oral squamous cell carcinoma based on network pharmacology and experimental validation.
    Zhang L; Ling Z; Hu Z; Meng G; Zhu X; Tang H
    Cancer Cell Int; 2021 Oct; 21(1):553. PubMed ID: 34674717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
    Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
    Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
    Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
    Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and MAPK/ERK1/2 Signaling Pathways.
    Dong Md S; Xu Md P; Yang Md P; Jiao Md J; Cheng Md PhD CS; Chen Md PhD L
    J Evid Based Integr Med; 2024; 29():2515690X241291381. PubMed ID: 39410848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
    Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
    J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deciphering the mechanism of Huang-Lian-Jie-Du-Decoction on the treatment of sepsis by formula decomposition and metabolomics: Enhancement of cholinergic pathways and inhibition of HMGB-1/TLR4/NF-κB signaling.
    Xu D; Lv Y; Wang J; Yang M; Kong L
    Pharmacol Res; 2017 Jul; 121():94-113. PubMed ID: 28434923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-Exactive Orbitrap HRMS and network pharmacology.
    Wang F; Mai J; Wang H; Xu Y; Zhou X; Xie Z; Yu B; Liu P; Liu W; Cheng Y
    J Ethnopharmacol; 2024 May; 325():117893. PubMed ID: 38336184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A network pharmacology integrated serum pharmacochemistry strategy for uncovering efficacy of YXC on hepatocellular carcinoma.
    Zhou TT; Zhu WJ; Feng H; Ni Y; Li ZW; Sun DD; Li L; Tan JN; Yu CT; Shen WX; Cheng HB
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117125. PubMed ID: 37699493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypolipidemic effect of the Chinese polyherbal Huanglian Jiedu decoction in type 2 diabetic rats and its possible mechanism.
    Zhang XJ; Deng YX; Shi QZ; He MY; Chen B; Qiu XM
    Phytomedicine; 2014 Apr; 21(5):615-23. PubMed ID: 24368167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
    Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
    J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma.
    Guo W; Huang J; Wang N; Tan HY; Cheung F; Chen F; Feng Y
    Front Pharmacol; 2019; 10():1185. PubMed ID: 31649545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ancient Chinese Medicine Herbal Formula Huanglian Jiedu Decoction as a Neoadjuvant Treatment of Chemotherapy by Improving Diarrhea and Tumor Response.
    Chan YT; Cheung F; Zhang C; Fu B; Tan HY; Norimoto H; Wang N; Feng Y
    Front Pharmacol; 2020; 11():252. PubMed ID: 32210825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro.
    Luo J; Chen QX; Li P; Yu H; Yu L; Lu JL; Yin HZ; Huang BJ; Zhang SJ
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116886. PubMed ID: 37429502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Huanglian-Jiedu decoction promotes adipose thermogenesis in obese mice by suppressing the expression of HDAC3.
    Xu P; Zhu Z; Zhou R; Wei Y; Xu F; Shen L; Wang Z; Xue Y; Yu X; Zhao J; Yan J; Jin Y; Fang P; Shang W
    J Ethnopharmacol; 2025 Jan; 336():118760. PubMed ID: 39216772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Huanglian jiedu decoction regulated and controlled differentiation of monocytes, macrophages, and foam cells: an experimental study].
    Li T; Han JY; Wang BB; Chen B; Li YM; Yu ZJ; Xue X; Zhang JP; Wang XB; Zeng H; Ma YL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1096-102. PubMed ID: 25335334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimization of combination modes of medical materials in extract of Huanglian Jiedu decoction by semi-bionic extraction].
    Dou J; Sun X; Zhang Z; Yu D; Li C
    Zhongguo Zhong Yao Za Zhi; 2010 May; 35(10):1256-60. PubMed ID: 20707193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the synergistic mechanism of Gegen Qinlian Decoction on the Wnt signaling pathway using an integrated strategy of network pharmacology and RNA-seq.
    Li Y; Gong Y; Zhang X; Wang J; Cheng Y; Liu F; Shi X; Xu W; Dong L
    J Ethnopharmacol; 2021 Oct; 278():114283. PubMed ID: 34098017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
    Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
    Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.